Mild Head Trauma in the Emergency Room: Assessment of the Risk of Intracranial Hemorrhage in Patients Receving Platelet Inhibitors.

Head Trauma Injury Clinical Trial

— Trauma-Head  

Official title:

Mild Head Trauma in the Emergency Room: Assessment of the Risk of Intracranial Hemorrhage in Patients Receving Platelet Inhibitors.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05589103
• Other study ID #: 7409
• Status: Recruiting
• Start date: January 1, 2020
• Est. completion date: December 31, 2022

Study information

• Verified date: October 2022
• Source: University Hospital, Strasbourg, France
• Contact: Florent BAICRY, MD
• Phone: 33 3 69 55 03 86
• Email: florent.baicry[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The clinical signs presented by a patient with a mild head injury are highly variable but remain strongly predictive of brain damage. The reference examination for the diagnosis of post-traumatic intracranial hemorrhage is currently the cerebral scanner without injection of contrast medium. Magnetic resonance imaging (MRI) tends to surpass CT in equipped centers, except for suspected bone lesions. The time required to perform brain imaging depends on the patient's clinical condition, comorbidities and treatments.

The responsibility of antiplatelet agents in post-traumatic intracranial hemorrhage is currently discussed, particularly with aspirin.

The hypothesis is that there is no significant difference in the proportion of intracranial hemorrhage in patients on antiplatelet agents after mild head trauma, in the absence of other factors favoring the occurrence of intracranial hemorrhage.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1692
• Est. completion date: December 31, 2022
• Est. primary completion date: December 2022
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria

• Adult patient (=18 years old)

• Visit to the emergency room of the Strasbourg University Hospital during 2017

• Victim of mild head trauma

• Patient who has given their consent to the reuse of their data for the purposes of this research.

Non-inclusion criteria

• Patient who expressed their opposition to participating in the study

• Subject under safeguard of justice

• Subject under guardianship or curatorship

• Patient on anticoagulant

• Non-isolated head trauma (AVP, fall greater than 6 meters, etc.)

Related Conditions & MeSH terms

• Craniocerebral Trauma
• Emergencies
• Head Trauma Injury
• Hemorrhage
• Intracranial Hemorrhages
• Wounds and Injuries

Locations

Country	Name	City	State
France	Service d'accueil des urgences - CHU de Strasbourg - France	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Propensity score on the factors influencing the taking of antiplatelet agents.		Files analysed retrospectively from January 01, 2017 to December 31, 2017 will be examined